United States - English - NLM (National Library of Medicine)

rna pharma, llc - aluminum zirconium trichlorohydrex gly (unii: t27d6t99lh) (aluminum zirconium trichlorohydrex gly - unii:t27d6t99lh) -

United States - English - NLM (National Library of Medicine)

rna pharma, llc - aluminum zirconium trichlorohydrex gly (unii: t27d6t99lh) (aluminum zirconium trichlorohydrex gly - unii:t27d6t99lh) -

Australia - English - Department of Health (Therapeutic Goods Administration)

dukehill healthcare pty ltd - 11111 - cystometer - this device is suitable for measurement of bladder volume in medical establishments. it can be used as an adjunct to perform clinical catheterization, also make evaluation of residual volume after the patient?s voiding and make auxiliary diagnosis of bladder disease and renal function. this device is also suitable for patients with a disability of the lower part of the body and have lost control of autonomous urinary function.

Australia - English - Department of Health (Therapeutic Goods Administration)

dukehill healthcare pty ltd - 37808 - probe, pulse oximeter, reusable - reusable spo2 sensor- adult and pediatric probes for compatible machines

Australia - English - Department of Health (Therapeutic Goods Administration)

dukehill healthcare pty ltd - 11248 - ultrasound unit, physical therapy - the painshield*md is intended to apply ultrasonic energy to create deep heat within body tissues for the treatment of selected medical conditions. the low intensity and low frequency ultrasound energy is effective within a diameter of 20cm and a depth approximately 3cm. the painshield*md can therefore be effective in treating a wound by proximity and without direct contact with it. selected medical conditions for treatment include. pain(including trigeminal neuralga), muscle spasm, joint contractors, provide improvement in local blood circulation, assist in soft tissue healing including post surgery, assist in healing chronic (such as diabetic) wounds), improve penetration of topical ointment or gel.

Australia - English - Department of Health (Therapeutic Goods Administration)

dukehill healthcare pty ltd - 63693 - urinary catheter ultrasonic bacterial adhesion inhibition system actuator - the uroshield actuator is attached onto the urinary catheter after the catheter is inserted into the patient. the actuator is active when attached to the uroshield driver. the actuator is intended for single patient use and should be changed with each catheter change.

Australia - English - Department of Health (Therapeutic Goods Administration)

dukehill healthcare pty ltd - 63691 - urinary catheter ultrasonic bacterial adhesion inhibition system - ?the uroshield? system is intended to prevent bacterial biofilm formation by generating ultrasound waves on the inner and outer surfaces of the catheter. the waves interfere with the attachment of bacteria (which is the initial step in biofilm formation) and increase antibiotic efficacy against biofilm bacteria. by means of the ultrasound waves that mitigate against biofilm formation, the uroshield? also reduces friction between the catheter and the patient?s internal tissues this helps to decrease the pain, discomfort and spasm associated with indwelling urinary catheters. the uroshield? driver is a low-energy, mains and battery powered medical device that supplies electrical signals to the actuator. the uroshield? actuator is attached onto the urinary catheter after the catheter is inserted into the patient. the actuator is intended for single patient use only

Australia - English - Department of Health (Therapeutic Goods Administration)

dukehill healthcare pty ltd - 65731 - physical therapy ultrasound system applicator, adhesive - a component of the painshield ultrasound therapy system that includes transducer held in place on the skin by a disposable adhesive patch

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ausrichter pty ltd - butorphanol base as butorphanol tartrate; benzethonium chloride - parenteral liquid/solution/suspension - butorphanol base as butorphanol tartrate alkaloid active 10.0 mg/ml; benzethonium chloride ammonium-quaternary other 0.1 mg/ml - analgesic+musculoskeletal - cat | dog | horse | bitch | castrate | cat - queen | cat - tom | colt | donkey | endurance horse | filly | foal | gelding | high - anaesthetic - local/general | analgesic | pre-anaesthetic | anaesthetic premedicant | antipyretic | colic | general anaesthetic | immobiliser | local anaesthetic | muscle relaxant | premedication | sedative | spasmolytic | tranquilliser | travel sickness

Israel - English - Ministry of Health

tzamal bio-pharma ltd - oxaliplatin - powder for solution for infusion - oxaliplatin 50 mg/vial - oxaliplatin - oxaliplatin - oxaliplatin in combination with 5-fluorouracil (5-fu) and folinic acid (fa) is indicated for: • adjuvant treatment of stage iii (duke‘s c) colon cancer after complete resection of primary tumor. • treatment of metastatic colorectal cancer. oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).